enkephalin, leucine and ER-Negative PR-Negative HER2-Negative Breast Cancer

enkephalin, leucine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Q; Guo, WH; Li, JB; Liu, J; Liu, WJ; Liu, XL; Yang, CQ; Yin, DC; Zhang, CY; Zhang, G; Zhang, SL; Zhao, G	1

Other Studies

1 other study(ies) available for enkephalin, leucine and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness. Molecular carcinogenesis, 2021, Volume: 60, Issue:8 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enkephalins; Extracellular Signal-Regulated MAP Kinases; Female; Gelatin; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Humans; Mice; MicroRNAs; Nanospheres; Protein Precursors; Proto-Oncogene Proteins c-fos; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2021

Article

Year

miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness.

Molecular carcinogenesis, 2021, Volume: 60, Issue:8

Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enkephalins; Extracellular Signal-Regulated MAP Kinases; Female; Gelatin; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Humans; Mice; MicroRNAs; Nanospheres; Protein Precursors; Proto-Oncogene Proteins c-fos; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2021